In vitro and in vivo assessment of heart-homing porous silicon nanoparticles.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biomaterials

• Publication date

  2016-07-01

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1016/j.biomaterials.2016.03.046PMID 27107168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells.

  2015cited by this paper
• Stability, cytotoxicity and cell uptake of water-soluble dendron–conjugated gold nanoparticles with 3, 12 and 17 nm cores

  2015cited by this paper
• A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors

  2015cited by this paper
• Porous Silicon Nanoparticles as Efficient Sensitizers for Sonodynamic Therapy of Cancer

  2015cited by this paper
• Porous silicon microparticles for delivery of siRNA therapeutics.

  2015cited by this paper
• Multifunctional porous silicon nanoparticles for cancer theranostics.

  2015cited by this paper
• Heart regeneration after myocardial infarction using synthetic biomaterials.

  2015cited by this paper
• Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure.

  2015cited by this paper
• Microcapsules engineered to support mesenchymal stem cell (MSC) survival and proliferation enable long-term retention of MSCs in infarcted myocardium.

  2015cited by this paper
• Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: Role of ROS and NF-κB

  2015cited by this paper
• On‐Chip Self‐Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications

  2015cited by this paper
• ポリウレタン/PTFEナノ粒子のコンポジットとナノコンポジットの表面特性,熱特性,および機械的特性 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター

  2014cited by this paper
• Fabrication and characterization of a chemically oxidized-nanostructured porous silicon based biosensor implementing orienting protein A.

  2014cited by this paper
• Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity

  2014cited by this paper
• Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering.

  2014cited by this paper
• Peptide modified gold nanoparticles for improved cellular uptake, nuclear transport, and intracellular retention.

  2014cited by this paper
• In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart.

  2014cited by this paper
• The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium.

  2014cited by this paper
• Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy

  2014cited by this paper
• Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy.

  2013cited by this paper
• Functional interaction between charged nanoparticles and cardiac tissue: a new paradigm for cardiac arrhythmia?

  2013cited by this paper
• The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility.

  2013cited by this paper
• Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair

  2013cited by this paper
• Nanostructured Porous Silicon‐Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release

  2013cited by this paper
• Anionic porphyrin-grafted porous silicon nanoparticles for photodynamic therapy.

  2013cited by this paper
• Annealing effect on photovoltaic performance of CdSe quantum-dots-sensitized TiO 2 nanorod solar cells

  2012cited by this paper
• Design of nanovectors for therapy and imaging of cardiovascular diseases.

  2012cited by this paper
• Cytotoxicity and cellular uptake of tri-block copolymer nanoparticles with different size and surface characteristics

  2012cited by this paper
• Biomaterial applications in cardiovascular tissue repair and regeneration

  2012cited by this paper
• Global gene expression changes in human embryonic lung fibroblasts induced by organic extracts from respirable air particles

  2012cited by this paper
• Nanostructured porous silicon materials: potential candidates for improving drug delivery.

  2012cited by this paper
• Functionalization of mesoporous silicon nanoparticles for targeting and bioimaging purposes

  2012cited by this paper
• Enthalpy of cooperative hydrogen bonding in complexes of tertiary amines with aliphatic alcohols: Calorimetric study

  2011cited by this paper
• Toxicology and clinical potential of nanoparticles

  2011cited by this paper
• Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.

  2011cited by this paper
• In-vitro cytotoxicity and cell uptake study of gelatin-coated magnetic iron oxide nanoparticles

  2011cited by this paper
• Induction and testing of hypoxia in cell culture.

  2011cited by this paper
• Identification of targeting peptides for ischemic myocardium by in vivo phage display.

  2011cited by this paper
• Sustained small interfering RNA delivery by mesoporous silicon particles.

  2010cited by this paper
• In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice.

  2010cited by this paper
• Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold.

  2010cited by this paper
• Effect of surface properties on nanoparticle-cell interactions.

  2010cited by this paper
• Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats.

  2010cited by this paper
• In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size.

  2010cited by this paper
• Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

  2009cited by this paper
• Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

  2009cited by this paper
• Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles.

  2009cited by this paper
• Biodegradable luminescent porous silicon nanoparticles for in vivo applications.

  2009cited by this paper
• Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association

  2009cited by this paper
• Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

  2008cited by this paper
• Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators.

  2007cited by this paper
• Acute β-Adrenergic Overload Produces Myocyte Damage through Calcium Leakage from the Ryanodine Receptor 2 but Spares Cardiac Stem Cells*

  2007cited by this paper
• Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

  2007cited by this paper
• Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells.

  2007cited by this paper
• Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?

  2007cited by this paper
• Synthesis and biomedical applications of functionalized fluorescent and magnetic dual reporter nanoparticles as obtained in the miniemulsion process

  2006cited by this paper
• Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes

  2006cited by this paper
• Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt.

  2005cited by this paper
• Molecular physiology of cardiac repolarization.

  2005cited by this paper
• Heart failure post-myocardial infarction: a review of the issues

  2005cited by this paper
• Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs.

  2005cited by this paper
• Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains.

  2004cited by this paper
• The role of hypoxia inducible factor 1alpha in cobalt chloride induced cell death in mouse embryonic fibroblasts.

  2004cited by this paper
• Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat Cells

  2004cited by this paper
• Stabilization of porous silicon surface by thermal decomposition of acetylene

  2004cited by this paper
• Heart failure.

  2003cited by this paper
• Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.

  2002cited by this paper
• Cardiac resynchronization in chronic heart failure.

  2002cited by this paper
• Long-term use of a left ventricular assist device for end-stage heart failure.

  2001cited by this paper
• Gene expression of natriuretic peptide receptors in myocardial cells.

  1995cited by this paper
• Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

  1995cited by this paper
• Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.

  1993cited by this paper
• Serum opsonins and liposomes: their interaction and opsonophagocytosis.

  1992cited by this paper
• Atrial natriuretic peptide: synthesis, release, and metabolism.

  1992cited by this paper
• Natriuretic peptide receptor mRNAs in the rat and human heart.

  1992cited by this paper
• Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments.

  1991cited by this paper
• Heart Failure

  1937cited by this paper
• Particle and Fibre Toxicology Particle and Fibre Toxicology Titanium Dioxide Nanoparticles Promote Arrhythmias via a Direct Interaction with Rat Cardiac Tissue Titanium Dioxide Nanoparticles Promote Arrhythmias via a Direct Interaction with Rat Cardiac Tissue

  year unknowncited by this paper

• Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease.

  2026cites this paper
• An updated overview of nanoparticle-induced cardiovascular toxicity

  2025cites this paper
• Ischemic Myocardium Targeting Peptide‐Guided Nanobubbles for Multimodal Imaging and Treatment of Coronary Microvascular Dysfunction

  2025cites this paper
• Nanoparticle-Based Targeted Drug Delivery Methods for Heart-Specific Distribution in Cardiovascular Therapy

  2025cites this paper
• Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases

  2025cites this paper
• Porous silicon and silica carriers for delivery of peptide therapeutics

  2024cites this paper
• Implantable patch of oxidized nanofibrillated cellulose and lysozyme amyloid nanofibrils for the regeneration of infarcted myocardium tissue and local delivery of RNA-loaded nanoparticles.

  2024cites this paper
• Role of Some Nanoparticles in Certain Cardiovascular System Diseases. A Review

  2024cites this paper
• A PEG-assisted membrane coating to prepare biomimetic mesoporous silicon for PET/CT imaging of triple-negative breast cancer.

  2024cites this paper
• Silicon-containing nanomedicine and biomaterials: materials chemistry, multi-dimensional design, and biomedical application.

  2024cites this paper
• Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity

  2024cites this paper
• Exploring the influence of silicon oxide microchips shape on cellular uptake using imaging flow cytometry

  2024cites this paper
• Targeting OGF/OGFR Signal to Mitigate Doxorubicin-induced Cardiotoxicity.

  2024cites this paper
• Nanoparticles for Creating a Strategy to Stimulate Liver Regeneration

  2024cites this paper
• Selective organ targeting nanoparticles: from design to clinical translation.

  2023cites this paper
• Nanoparticles for targeted drug delivery in modern cardiology

  2023cites this paper
• Use of Silica Nanoparticles for Drug Delivery in Cardiovascular Disease.

  2023cites this paper
• Allogenic Stem Cells Carried by Porous Silicon Scaffolds for Active Bone Regeneration In Vivo

  2023cites this paper
• Nanoparticle Based Cardiac Specific Drug Delivery

  2023cites this paper
• Gelatin‐Lysozyme Nanofibrils Electrospun Patches with Improved Mechanical, Antioxidant, and Bioresorbability Properties for Myocardial Regeneration Applications

  2022cites this paper
• Protease-targeting peptide-functionalized porous silicon nanoparticles for cancer fluorescence imaging.

  2022cites this paper
• Strategies and challenges for non-viral delivery of non-coding RNAs to the heart.

  2022cites this paper
• Microfluidic Techniques for Next‐Generation Organoid Systems

  2022cites this paper
• Role of Biomaterials in Cardiac Repair and Regeneration: Therapeutic Intervention for Myocardial Infarction.

  2022cites this paper
• Molecular scale study on the interactions of biocompatible nanoparticles with macrophage membrane and blood proteins

  2022cites this paper
• Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects

  2022cites this paper
• In Vivo Kidney Allograft Endothelial Specific Scavengers for On-Site Inflammation Reduction under Antibody-Mediated Rejection.

  2022cites this paper
• Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury

  2022cites this paper
• Nanomaterials aimed toward the cardiac mitochondria: from therapeutics to nanosafety

  2021cites this paper
• Radiolabeled porous silicon for nuclear imaging and theranostic applications

  2021cites this paper
• In Vitro Evaluation of the Therapeutic Effects of Dual‐Drug Loaded Spermine‐Acetalated Dextran Nanoparticles Coated with Tannic Acid for Cardiac Applications

  2021cites this paper
• Nanoparticles: Promising Tools for the Treatment and Prevention of Myocardial Infarction

  2021cites this paper
• A non-invasive nanoparticles for multimodal imaging of ischemic myocardium in rats

  2021cites this paper
• Local intramyocardial delivery of bioglass with alginate hydrogels for post-infarct myocardial regeneration.

  2020cites this paper
• Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction.

  2020cites this paper
• Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications

  2020cites this paper
• Evaluation of the potential of nanoparticles containing active substances in selected chronic diseases.

  2020cites this paper
• Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb.

  2020cites this paper
• Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease

  2020cites this paper
• Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions

  2020cites this paper
• Therapeutic advances in cardiac targeted drug delivery: from theory to practice

  2020cites this paper
• Hybrid red blood cell membrane coated porous silicon nanoparticles functionalized with cancer antigen induce depletion of T cells

  2020cites this paper
• Nanomaterials for Cardiac Tissue Engineering

  2020cites this paper
• Identification and characterization of small molecule modulators of cardiac hypertrophy

  2020cites this paper
• Cell–biomaterial interactions: the role of ligand functionalization

  2020cites this paper
• Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics.

  2020cites this paper
• Nanoparticle delivery of cardioprotective therapies.

  2020cites this paper
• Nanomedicine Therapies

  2019cites this paper
• Biohybrid Cloaked Nanovaccines For Cancer Immunotherapy

  2019cites this paper
• Porous silicon microcarriers for extended release of metformin: Design, biological evaluation and 3D kinetics modeling

  2019cites this paper
• Super-Elastic Magnetic Structural Color Hydrogels.

  2019cites this paper
• Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model

  2019cites this paper
• Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke.

  2019cites this paper
• Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats

  2019cites this paper
• Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers.

  2019cites this paper
• Nanomedicines to tackle myocardial infarction: where are we now and where are we going?

  2019cites this paper
• Hierarchical Nanostructuring of Porous Silicon with Electrochemical and Regenerative Electroless Etching.

  2019cites this paper
• Approaches to improve the biocompatibility and systemic circulation of inorganic porous nanoparticles.

  2018cites this paper
• Biodegradation of inorganic drug delivery systems in subcutaneous conditions

  2018cites this paper
• 3D printing: prospects and challenges

  2018cites this paper
• Multimodality Imaging of Silica and Silicon Materials In Vivo

  2018cites this paper
• Cellular Internalization-Induced Aggregation of Porous Silicon Nanoparticles for Ultrasound Imaging and Protein-Mediated Protection of Stem Cells.

  2018cites this paper
• Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy

  2018cites this paper
• Big Potential From Silicon-Based Porous Nanomaterials: In Field of Energy Storage and Sensors

  2018cites this paper
• Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation

  2018cites this paper
• Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics

  2018cites this paper
• Thermally Carbonized Porous Silicon and Its Recent Applications

  2018cites this paper
• Advances in Porous Silicon–Based Nanomaterials for Diagnostic and Therapeutic Applications

  2018cites this paper
• Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction

  2018cites this paper
• Dual‐Drug Delivery Using Dextran‐Functionalized Nanoparticles Targeting Cardiac Fibroblasts for Cellular Reprogramming

  2018cites this paper
• Gelatin-based porous silicon hydrogel composites for the controlled release of tramadol

  2018cites this paper
• Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling.

  2017cites this paper
• Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle‐Like Functions

  2017cites this paper
• Theranostic Imaging with Porous Silicon

  2017cites this paper
• Multifunctional Nanoparticles for Targeted Drug Delivery and Imaging for Ischemic Myocardial Injury

  2017cites this paper
• Emerging Trends in Micro- and Nanoscale Technologies in Medicine: From Basic Discoveries to Translation.

  2017cites this paper
• RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model.

  2017cites this paper
• Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles

  2017cites this paper
• Polymer Nanocomposites via Click Chemistry Reactions

  2017cites this paper
• Nanomedicine for the cardiac myocyte: Where are we?

  2017cites this paper
• Bioprinting 3 D microfibrous scaffolds for engineering endothelialized myocardium and heart-ona-chip

  2016cites this paper
• Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells.

  2016cites this paper
• Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip.

  2016cites this paper
• The efficiency of maltodextrin and porous silicon nanoparticles for the in vitro and in vivo stabilization of tyrosine hydroxylase

  2016cites this paper
• Synthesis, Characterization and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles-Nucleic Acids Complexes Absence of Soluble Polymer as a Protective Agent Using Nucleic Acids Condensation and Solution Reduction Method

  2016cites this paper